Expert Interview
Getting a payor's perspective on vutrisiran (AMVUTTRA), tafamidis (Vyndamax / Vyndaqel), and acoramidis (Attruby) for ATTR-CM.
Ticker(s): ALNY, PFE, BBIOInstitution: Self Employed
- Healthcare executive with over 10 years of experience in pharmacy benefit management (PBM) and healthcare operations.\
- Extensive knowledge of the PBM business models, rebate structure, cost management strategies, formulary
management, pharmacy claims, and managed care principles
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
